The usefulness and optimal timing of laboratory coagulation tests before obstetric extradural analgesia are controversial. Moreover, the significance of mild coagulation abnormalities during pregnancy remains unclear. We have assessed the reliability of coagulation tests performed several weeks before delivery as predictors of coagulation abnormalities during labour.
Summary
The usefulness and optimal timing of laboratory coagulation tests before obstetric extradural analgesia are controversial. Moreover, the significance of mild coagulation abnormalities during pregnancy remains unclear. We have assessed the reliability of coagulation tests performed several weeks before delivery as predictors of coagulation abnormalities during labour.
Platelet count, plasma fibrinogen concentration, prothrombin time (PT) and activated partial thromboplastin time (aPTT) were sampled in 797 women during the ninth month of pregnancy and checked during labour. Platelet count was less than 100 10 9 litre 91 for 11 women during labour. Only three had been detected by the first sample. Platelet count less than 100 10 9 litre 91 or fibrinogen concentration less than 2.9 g litre 91 during labour were associated with an increase in the incidence of postpartum haemorrhage (odds ratio:19.7). We conclude that a platelet count several weeks before delivery was not reliable in predicting thrombocytopenia during labour and that women with mild coagulation abnormalities in early labour may need special attention regarding the risk of postpartum haemorrhage, (Br. J. Anaesth. 1997; 78: 678-683).
In a recent survey of 435 French obstetric units, 1 most anaesthetists advocated laboratory coagulation tests before extradural analgesia for labour. In this study, coagulation tests were performed during the ninth month of pregnancy in 74% of obstetric units surveyed. They included prothrombin time (PT), activated partial thromboplastin time (aPTT) and platelet count in almost all cases-Although haemostasis disorders seem to increase the risk of extradural haematoma, 2 the usefulness of laboratory coagulation screening tests is still debatable. 3 However, platelet count can decrease during pregnancy 4 and the incidence of thrombocytopenia has been shown to increase during labour. 5 The significance of this thrombocytopenia remains unclear and determination of a safe lower platelet count limit before performing extradural analgesia is still controversial. Many anaesthetists avoid extradural analgesia if platelet count is less than 100 10 9 litre 91 , 6-8 but this limit has no supporting data. 9 Another difficulty in coagulation assessment is the choice of when to perform it. Haemostasis disorders can appear late in pregnancy. Therefore, a medical history, physical examination and laboratory testing may be inadequate in detecting these haemostasis disorders if they are performed too early. 10 In addition, no relationship between mild coagulation abnormalities during pregnancy and haemorrhagic complications during extradural analgesia 11 or delivery 12 have yet been established. Therefore, we designed a prospective study to evaluate the accuracy of laboratory coagulation tests performed during the ninth month of pregnancy to predict coagulation abnormalities during labour. We also examined the incidence of these coagulation abnormalities during labour and their relationship with post-partum haemorrhage (PPH).
Patients and methods
This prospective surveillance study was performed between 1 June 1995 and 31 December 1995. During this period, we studied all women with a singleton pregnancy who came into the labour ward for delivery. As the study was an anonymous survey of haematological and clinical variables, hospital Ethics Committee approval was not required. Inclusion criteria were: pre-anaesthetic clinical assessment during the ninth month of pregnancy, physical status ASA I or II, and term 936 and :42 weeks at the time of delivery. We excluded all women with a medical history known to be associated with haemostasis disorders, such as von Willebrand disease, diabetes mellitus, idiopathic thrombocytopenic purpura or lupus erythematosus. We also excluded women receiving anticoagulant therapy and parturients admitted for elective Caesarean section. ) was confirmed by examination of the stained peripheral blood film to exclude platelet clumping. BS 2 was always available before the decision to proceed with extradural analgesia. If indicated, extradural analgesia was provided for labour in each parturient whose platelet count was more than 100 10 9 litre 91 at BS 2. When the women left the labour ward, the route of delivery (vaginal delivery or Caesarean section) and the occurrence of PPH were noted. Only significant haemorrhages were considered. These were defined as clinically severe bleeding requiring volume expansion and manual uterine exploration, associated with either blood transfusion or a significant decrease (ജ2 g dl
91
) in haemoglobin concentration, or both, within 24 h post-partum.
We compared for each parturient the results of BS 1 and BS 2, and we calculated the changes in platelet count (%) and fibrinogen concentration (g litre
) between the two periods. Then we examined mean (SD) platelet count and fibrinogen concentration in BS 2. Values less than the lower threshold of the corresponding 95% confidence limits (value ഛmean value 91.96 SD) for one or both variables, or with a PT :70% or an aPTT 940 s (normal 30 s) were classified as "coagulation abnormalities". We compared the incidence of severe PPH in this group and in the other women.
STATISTICAL ANALYSIS
Results are expressed as mean (SD). For quantitative data, statistical analysis was performed using analysis of variance for repeated measures. When overall differences were detected, individual comparisons between groups were performed by Student's t test with Bonferroni's correction. Fisher's exact test was used to compare nominal data.
Results
We studied 835 parturients: 797 were included in the results and statistical analyses, and 38 were excluded. The characteristics of these 38 patients in the labour ward are shown in table 1. Mean delay between BS 1 and BS 2 was 17 (9) days (always less than 30 days).
PLATELET COUNT
Mean values for platelet count in BS 1 and BS 2 were, respectively, 216 fig. 3 ).
COAGULATION DISORDERS IN EARLY LABOUR AND PPH
The mode of delivery was vaginal for 677 women and a Caesarean section was performed in the other 120. Among the 677 who had a vaginal delivery, 46 had significant PPH (table 2) and all occurred in patients asymptomatic for haemostasis disorders before delivery. They were all considered as clinically significant haemorrhages requiring volume expansion (Ringer's solution, blood transfusion, or both) and manual uterine exploration. In two patients, hysterectomy was necessary to stop massive haemorrhage. Mean Figure 3 Variations (in absolute value) in plasma fibrinogen concentration between the two samples, BS 1 and BS 2, for women who had a plasma fibrinogen concentration less than 2.9 g litre 91 (mean value 91.96 SD at BS 2) in either one or both samples. The shaded area indicates the area below 2.9 g litre 91 . Platelet count and fibrinogen concentration at BS 2 were significantly lower in women with PPH than in those who did not bleed (table 2) . If one or both of these variables were below the corresponding "mean value 91.96 SD" threshold, the incidence of PPH was increased significantly compared with the other women ( fig. 4) . Sensitivity, specificity, positive and negative predictive values for both BS 1 and BS 2 for low fibrinogen predicting subsequent PPH are presented in table 3.
Discussion
In our study, the percentage of women with platelet count values less than 100 10 9 litre 91 and less than 150 10 9 litre 91 increased, respectively, from 0.5 to 1.4% and from 7.3 to 12.4% between BS 1 and BS 2. These results are in agreement with those of Rolbin and colleagues who measured platelet count in 1621 healthy women. 9 Only seven (0.4%) and 104 (6.4%) had platelet counts less than 100 and 150 10 9 litre 91 , respectively. However, these results were obtained either during pregnancy or in the post-partum period. All patients were asymptomatic, but some had significant thrombocytopenia (lower platelet count 21 Gestational thrombocytopenia is quite common but its significance is still unclear. The decrease in platelet count could be related to haemodilution and acceleration of platelet turnover with increased production of platelets from the bone marrow and increased trapping or destruction at the placental level. This quantitative decrease in platelet count could be counterbalanced by a marked increase in platelet reactivity during pregnancy. 13 On the other hand, some authors have described decreased platelet activation during pregnancy 14 15 and suggested the presence of a plasma factor that selectively inhibits prostaglandin-dependent activation. 15 Therefore, it remains difficult in clinical practice to define precisely the clotting capacities of a woman with a mild gestational thrombocytopenia.
The risk of spinal haematoma has been estimated to be approximately 1 in 150 000 after extradural analgesia. 2 Even if the risk of this complication is increased in patients with a low platelet count, it is difficult to define the safe lower threshold for platelet count. The haematological definition of thrombocytopenia is a platelet count less than 150 10 9 litre
91
. The lower limit of 100 10 9 litre 91 for platelet count, often judged as "safe" to perform extradural analgesia, [6] [7] [8] has no supporting data. In the absence of any other coagulation disorder, some authors would prefer to lower this limit to 80 10 9 litre
. 16 Nevertheless, some authors do not systematically observe the platelet count before extradural analgesia. 7 8 Rolbin and colleagues estimated that in their institution approximately 5000 thrombocytopenic parturients have benefitted from extradural analgesia over a 30-yr period without any spinal haematomas. 9 The same team has reported the case of uncomplicated extradural analgesia in an asymptomatic parturient whose platelet count was 2 10 9 litre 91 immediately after delivery. 7 Whatever the significance of these low platelet counts and the acceptable limit, one remaining problem is the choice of the appropriate time to perform a platelet count. Indeed, some authors found a decrease in mean platelet count whereas others reported no change in platelet count during pregnancy. 17 Many anaesthetists consider it sensible to obtain the results of coagulation tests several weeks before extradural analgesia. 1 However, our study showed that the result of this nine month platelet count was useless in predicting platelet count less than 100 10 9 litre 91 during labour. The nature of the other laboratory tests which are useful before extradural analgesia and their lower "safe value" are still debatable. Coagulation tests such as PT and aPTT measurements have not been studied extensively in obstetric patients but they seem to be less useful for early detection of haemostasis disorders during labour. 18 Indeed, these tests were always normal in our study. Therefore, we believe that these tests should no longer be performed in clinically normal parturients before extradural analgesia.
Fibrinogen concentration increases physiologically during pregnancy. 19 20 A safe lower limit for plasma fibrinogen concentration has not been evaluated, while the safe laboratory lower limit defined for the general population may not be appropriate for pregnant women. Nevertheless, we had to define a lower limit of normality for both of these variables. Therefore, all values for either platelet count or fibrinogen concentration at BS 2 which were below the lower threshold of the corresponding 95% confidence limit were considered as abnormal.
Our study has shown that significant PPH were more frequent when platelet count or fibrinogen concentration, or both, were low in early labour. In previous studies, this association has not been recognized as a significant factor associated with PPH. 12 The significance of the relationship between these mild coagulation abnormalities and the occurrence of PPH is not clear. During pregnancy, biological changes occur such as an increase in many clotting factor concentrations and placental synthesis of plasminogen activator inhibitor. Early in pregnancy, intravascular fibrin deposition can be found in the uteroplacental circulation. 19 This reflects local chronic intravascular coagulation which induces local fibrinolysis. 21 22 These biological changes are associated with mechanical factors that limit the risk of bleeding, such as structural changes in the spiral arteries and myometrial contractions. 6 19 These physiological changes must prepare the pregnant woman for delivery and placental separation and the inherent risk of haemorrhage. In case of failure of the mechanical protective mechanisms, there is an increased need for haemostatic components such as fibrinogen and platelets. We may hypothesize that in such situations there is inadequate compensation which is reflected in a low platelet count and a low fibrinogen plasma concentration. Combs, Murphy and Laros showed that the main clinical variables related to the risk of PPH were prolonged labour and factors associated with uterine atony. 12 If impaired uterine contractility occurred in patients with a low platelet count and fibrinogen concentration, local coagulation factors may not ensure good haemostasis and therefore, at the time of delivery, an increased incidence of PPH could occur. This hypothesis of a relationship between obstetric factors and mild coagulation abnormalities may explain the occurrence of PPH, but this will require further studies.
In clinical practice, detection of coagulation abnormalities, and especially detection of thrombocytopenia, may be important in the management of the obstetric patient. Nevertheless, unhelpful coagulation tests should be avoided.
Our results demonstrated that coagulation tests performed several weeks before labour should be abandoned and that PT and aPTT are unnecessary in clinically normal parturients.
